| |
Biomarkers & Nanoparticles Committee
Committee Chairs
Annual Symposium Synopsys
Nanodevices and nanoparticles enable study of a wide range of biological
phenomena extending from protein-protein interaction mapping to cancer detection
in intact animals and man. Recent advances in materials science, in particular
the development of functionalized nanoparticles, united with advances in
molecular imaging research, provide the impetus for the present explosion in
nanobiotechnology imaging research.
Key to those advances is the emergence of functionalized nanoparticles,
particularly quantum dots (QDs) that can be targeted specifically to receptors,
enzymes, transporters and other molecules of biological importance that can
interact at the cellular level. Additionally, over the last five years there has
been a proliferation of high-resolution devices for in vivo imaging in animal
models of human disease and high-throughput, i.e., microarray and combinatorial,
techniques for generating new diagnostic and therapeutic targets and probes.
Nanotechnology in the Life-sciences is omnipresent. Several biological systems
operate at the nanoscale with remarkable precision and regulation. A fine
example is that of biomolecular motor proteins, designed by nature to carry out
critical functions in the cell. Most of the properties of these proteins are
nanoscale, be they size or time of operation. While systems such as motors have
been isolated, modified and studied in detail at the biochemical level, much
needs to be done at the level of hybrid structures with interfaces to inorganic
materials. Further, scaling laws need to be understood in order to bridge
between single molecules and higher order devices or architectures.
A similar situation is encountered with biomaterials, another area with
tremendous application potential. Alongwith these topics, this symposium will
also cover the equally important area of biomolecular analysis, which has
reached new levels of sensitivity, precision and resolution due to advances in
other sciences. Thus, topics scuh as fluidics, detection methods and
engineering approaches will receive enhanced attention. Drug design and
delivery is poised the interface of several topics such as receptor signaling,
computational modeling, targeted design, nanoscale biomaterials and
toxicological profiles.
We invite submissions in each of these areas and related topics. A sample
listing of pertinent topics is listed below. This is by no means an exclusive
list, but aims to give a general overview of this diverse symposium topic.
Topics & Application Areas
- Quantum Dots
- Fullerenes
- Lipids
- Polymers
- Dendrimers
|
- Dendrimers
- DNA-Gold-Nanoparticle Conjugates
- Fluorescent & Luminescent Particles
- Nucleic Acid Ligands (aptamers)
- Targeted Functionalization of Nanoparticles
|
Submit Proposal or Comment to Committee Chair
We encourage you to participate and to submit your interest as either an
Scientific Committee Member or to organize a Scientific Committee*. The
NSTI will provide the infrastructure for each Industrial Committee to
organize and present a focused Symposium at the annual Nanotech
Conference and Trade Show (Nanotech 2008,
Boston, Massachusetts, June 1-5, 2008). Details will be provide upon approval of
proposal.
* All submissions will be reviewed by the NSTI Scientific Committee
Chairs and a timely response will be issued.
Back to NSTI Scientific Leadership Committees
|
